Sign on doorway for FTC in Washington DC
Pharma

Trump's nominee to chair the FTC could bode well for pharma M&A

As Donald Trump fills out his cabinet, the President-elect’s latest pick could bode well for biopharma business development over the next four years.
Fraiser Kansteiner Dec 11, 2024 11:25am
A strategic roadmap for your biologics manufacturing

A strategic roadmap for your biologics manufacturing

Dec 9, 2024 8:00am
David Ricks

How will Trump approach healthcare? Lilly CEO gives some hints

Dec 11, 2024 10:56am
Whats next in AIs drug discovery journey

What’s next in AI’s drug discovery journey

Dec 9, 2024 8:00am
signing contract

Vertex, Saudi Arabia ink MoU to boost gene therapy production

Dec 11, 2024 10:56am
Gilead

Gilead spotlights lenacapivir in plan to hold on to HIV crown

Dec 11, 2024 10:53am
Marketing News

Boehringer, Lilly bring kidney disease test push to Rose Parade

Dec 9, 2024 4:05pm

AbbVie CLL survey shows emotional impact on patients of color

Dec 9, 2024 11:48am

Omnicom, Interpublic ink deal to make world’s largest ad agency

Dec 9, 2024 10:40am

Acadia nabs Lexicon alum as new commercial lead

Dec 9, 2024 9:26am